Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Censoring Survival Data01:09

Censoring Survival Data

57
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
57
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

82
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
82
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

134
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
134
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

86
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
86
Residuals and Least-Squares Property01:11

Residuals and Least-Squares Property

7.3K
The vertical distance between the actual value of y and the estimated value of y. In other words, it measures the vertical distance between the actual data point and the predicted point on the line
If the observed data point lies above the line, the residual is positive, and the line underestimates the actual data value for y. If the observed data point lies below the line, the residual is negative, and the line overestimates the actual data value for y.
The process of fitting the best-fit...
7.3K
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

26
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
26

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Long-term follow-up of oral decitabine/cedazuridine plus venetoclax for older or unfit patients with newly diagnosed acute myeloid leukemia.

Haematologica·2026
Same author

Vibecotamab for measurable residual disease in acute myeloid leukemia and for myelodysplastic syndromes and chronic myelomonocytic leukemia after hypomethylating agent failure: a phase II study.

Journal of hematology & oncology·2026
Same author

Toolkit for multistate disease progression simulation and treatment decision-making aid.

BMC medical research methodology·2026
Same author

Long-Term Outcomes of Azacitidine, Venetoclax and Gilteritinib in Newly Diagnosed FLT3-Mutated AML.

Blood advances·2026
Same author

Blinatumomab and Ponatinib Versus Hyper-CVAD and Ponatinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Propensity Score Analysis.

American journal of hematology·2026
Same author

Outcome of second-line therapy in adult B-cell acute lymphoblastic leukemia.

Cancer·2026

相关实验视频

Updated: May 30, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

对于具有双重审查数据的线性转换模型的有效推断.

Sangbum Choi1, Xuelin Huang2

  • 1Department of Statistics, Korea University, Seoul 02841, South Korea.

Communications in statistics: theory and methods
|January 29, 2025
PubMed
概括

这项研究引入了一种新的方法来分析医疗数据,使用双重审查,提高艾滋病毒/艾滋病试验的准确性. 非参数最大概率估计 (NPMLE) 为转换模型提供了高效和可靠的结果.

科学领域:

  • 生物统计学 生物统计学
  • 生存分析的分析.
  • 医疗信息学 医疗信息学

背景情况:

  • 医学研究,特别是艾滋病毒/艾滋病临床试验,经常遇到双重审查的数据.
  • 这种数据类型包括精确和间隔审查的观测,这给分析带来了挑战.

研究的目的:

  • 为双重审查下的半参数转换模型开发和评估一种非参数最大概率估计 (NPMLE) 方法.
  • 为医学研究中分析复杂的生存数据提供一个强大的统计框架.

主要方法:

  • 直接最大化非参数概率函数以估计回归和干扰参数.
  • 使用观察到的信息矩阵的逆向来进行统计推理.

主要成果:

  • 拟议的NPMLE是一致的,并且在异常上正常.
  • 模拟研究证实了该方法的有效性,即使有大量的审查,也超过了现有的基于函数的估计方法.
  • 该方法在模拟中显示出更高的效率.

结论:

  • NPMLE提供了一种高效可靠的方法,用于半参数转换模型与双重审查的数据.
  • 该方法适用于现实世界的医学数据,如艾滋病临床试验分析所示.
关键词:
案例-1 审查审查经验过程是经验过程.时间间隔审查.非参数的可能性.相称的危险相称的危险.有比例的赔率是相称的.自我一致性 自我一致性

更多相关视频

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.4K

相关实验视频

Last Updated: May 30, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.4K